Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

An Alliance of Giants

| Rob Coker | 4 min read

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

Business & Regulation Profession

The Power List 2023 Is Live

| Stephanie Vine

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Manufacture Bioprocessing - Upstream & Downstream

Future-Proofing Aseptic Filling

| Adam Pinkert, Áine Brennan | 6 min read

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing

Business & Regulation Digital Technologies

Entering the Modern Era for Data-Driven Quality Control

| Jason Boyd, Simon Meffan-Main | 4 min read

A new class of modern cloud systems promises the next step change in QC productivity and data integrity.

Business & Regulation Business Practice

Social Media Reacts to Eli Lilly’s Price Reduction of Insulin

| Stephanie Vine | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?

Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Business & Regulation Business Practice

A Roadmap to Greener Pharma Logistics

| Julius Graf von Pfeil, Kees Schmidt | 10 min read

How to make the art of pharmaceutical logistics more sustainable.

Business & Regulation Business Practice

Focusing on Sustainability

Download our eBook to find out how the industry is trying to be more sustainable.

Business & Regulation Trends & Forecasts

Weathering the Storm: Cell and Gene’s Economic Downturn

| James Wilson, Anshul Mangal | 5 min read

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Vine | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register